Alpha Cognition Inc. (ACOG)
NASDAQ: ACOG · Real-Time Price · USD
5.78
+0.12 (2.12%)
Nov 20, 2024, 4:00 PM EST - Market closed
Company Description
Alpha Cognition Inc., a clinical stage biopharmaceutical company, engages in the development of treatments for Alzheimer’s disease and amyotrophic lateral sclerosis (ALS).
The company offers ZUNVEYL (benzgalantamine) for the treatment of mild-to-moderate Alzheimer’s disease and mild traumatic brain injury.
It also develops ALPHA-0602, a gene therapy for the treatment of ALS; and ALPHA-0702 and ALPHA-0802, a granulin epithelin motifs for the treatment of neurodegenerative diseases.
The company was formerly known as Crystal Bridge Enterprises Inc. and changed its name to Alpha Cognition Inc. in March 2021.
Alpha Cognition Inc. was founded in 2000 and is headquartered in Vancouver, Canada.
Alpha Cognition Inc.
| Country | Canada |
| Founded | 2000 |
| CEO | Michael McFadden |
Contact Details
Address: 750 West Pender Street, Suite 1200 Vancouver, BC V6C 2T8 Canada | |
| Phone | 858-344-4375 |
| Website | alphacognition.com |
Stock Details
| Ticker Symbol | ACOG |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001655923 |
| ISIN Number | CA02074J5017 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Michael McFadden | Chief Executive Officer |
| Henry Du | Chief Financial Officer |
| Lauren D’Angelo | Chief Operating Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 18, 2024 | 8-K | Current Report |
| Nov 18, 2024 | D | Notice of Exempt Offering of Securities |
| Nov 15, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Nov 15, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Nov 13, 2024 | 424B4 | Prospectus |
| Nov 12, 2024 | CERT | Certification by an exchange approving securities for listing |
| Nov 12, 2024 | S-1MEF | Registration adding securities to prior Form S-1 registration |
| Nov 12, 2024 | POS EX | Filing |
| Nov 8, 2024 | EFFECT | Notice of Effectiveness |